Celldex Therapeutics
CLDX
#4701
Rank
HK$15.22 B
Marketcap
HK$229.17
Share price
-0.51%
Change (1 day)
13.01%
Change (1 year)

Celldex Therapeutics (CLDX) - Cash on Hand

Cash on Hand as of September 2025 : HK$4.53 Billion

According to Celldex Therapeutics's latest financial reports the company has HK$4.53 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Celldex Therapeutics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31HK$5.63 B70.2%
2023-12-31HK$3.30 B38.85%
2022-12-31HK$2.38 B-25.15%
2021-12-31HK$3.18 B111.21%
2020-12-31HK$1.50 B200.58%
2019-12-31HK$0.50 B-31.9%
2018-12-31HK$0.73 B-32.41%
2017-12-31HK$1.08 B-25.98%
2016-12-31HK$1.47 B-34.5%
2015-12-31HK$2.24 B44.09%
2014-12-31HK$1.55 B-33.63%
2013-12-31HK$2.34 B261%
2012-12-31HK$0.65 B57.17%
2011-12-31HK$0.41 B-12.92%
2010-12-31HK$0.47 B-25.63%
2009-12-31HK$0.63 B86.94%
2008-12-31HK$0.34 B793.42%
2007-12-31HK$38.27 M-87.97%
2006-12-31HK$0.31 B75.24%
2005-12-31HK$0.18 B-26.39%
2004-12-31HK$0.24 B57.14%
2003-12-31HK$0.15 B-19.71%
2002-12-31HK$0.19 B-41.23%
2001-12-31HK$0.33 B-14.99%
2000-12-31HK$0.39 B269.88%
1999-12-31HK$0.10 B53.44%
1998-12-31HK$68.95 M39.03%
1997-12-31HK$49.59 M-49.11%
1996-12-31HK$97.45 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Seagen
SGEN
HK$9.62 B 112.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
HK$26.9 M-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
HK$1.91 B-57.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$73.49 B 1,519.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$116.60 B 2,469.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$34.58 B 662.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
HK$21.81 M-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA